AND EXCHANGE COMMISSION
to Section 13 or 15(d) of the Securities Exchange Act of 1934
of report (date of earliest event reported): February 16, 2018
Crypto Technologies, Inc.
(Exact Name of Registrant as Specified in its Charter)
File No.: 000-15746
or other jurisdiction of incorporation or organization)
Wall Street, 28th Floor, NY
of Principal Executive Offices)
Telephone Number, including area code: (212) 400-7198
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2. below):
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)|
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)|
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))|
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))|
3.02 Unregistered Shares of Equity Securities.
February 16, 2018, Virtual Crypto Technologies, Inc., f/k/a Emerald Medical Applications Corp. (the “Registrant”)
filed a Form 8-K with disclosure under Item 3.02 reporting that from January 31, 2018 through February 13, 2018, the Registrant
issued and sold a total of 19,647,856 restricted shares and received subscription proceeds of $1,375,700 from “accredited
investors” in consideration for the issuance of units (the “Units”) at an offering price of $0.07 per Unit,
each Unit consisting of: (i) one (1) share of common stock (the “Shares”); and (ii) one (1) common stock purchase
warrant exercisable for a period of twenty-four (24) months to purchase one (1) additional Share at an exercise price of $0.14.
The foregoing is hereinafter referred to as the “$0.07 Unit Offering.” An additional 13 subscribers under the $0.07
Unit Offering, who subscribed during the period set forth above, submitted their subscription proceeds after February 16, 2018
and, as a result, the Registrant issued an additional 3,928,571 restricted shares through March 13, 2018 and, in connection therewith,
the Registrant received additional subscription proceeds of $277,100.
offer and sale of the Units in the $0.07 Unit Offering, without registration under the Securities Act of 1933, as amended (the
“Act”), was made in reliance upon the exemption provided Regulation S and Regulation D promulgated by the Securities
and Exchange Commission under the Act.
addition, on March 20, 2018, the Registrant issued a total of 1,092,500 restricted shares as follows: (i) 62,500 restricted shares
were issued to Guy Shalom, a resident of Israel, in consideration for the exercise of a stock option at an exercise price of $0.01
per share, which options were granted in connection with a services rendered in October 2016; (ii) 300,000 restricted shares were
issued to Yair Fudim, a resident of Israel, pursuant to a Services Agreement for serving as the Registrant’s CEO, which
shares were valued at $0.01 per share; and (iii) 730,000 restricted shares were issued to Lyons Capital LLC, an accredited investor
organized under the laws of the State of Florida, in connection with services under a six-month engagement letter/services agreement
(“Engagement Letter”), which shares were valued at $124,100, based on the closing share price on the day prior to
the Engagement Letter.
on March 19, 2018, Tamarid Ltd, an accredited investor organized under the laws of Israel, converted a note in the principal amount
of $9,218 into 921,800 shares, based upon the note conversion price of $0.01 per share. The note was originally issued in June
foregoing 2,014,300 shares were issued without registration under the Act in reliance upon the exemptions provided under Section
4(2) of the Act and Regulations S and D, as well as Rule 144, promulgated by the SEC under the Act.
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
Chief Executive Officer
March 21, 2018